RecruitingPhase IIEN originalBreast cancerTriple negative (TNBC)

A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

The purpose of this study is to find out if it is practical (feasible) to give dose-dense CMF (cyclophosphamide, methotrexate, and fluorouracil) in two standard chemotherapy regimens in people with breast cancer, age 70 and older.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Wiek co najmniej 70 lat
  • Potwierdzony histologicznie rak piersi (adenocarcinoma)
  • Biopsja lub operacja przeprowadzona w ciągu 3 miesięcy przed włączeniem do badania
  • Wyniki badań HER-2/neu, receptora estrogenowego i progesteronowego dostępne
  • Wydolność ogólna pozwalająca na udział w badaniu (wynik ECOG ≤2 lub Karnofsky'ego ≥60%)
  • Prawidłowe wartości laboratoryjne: liczba neutrofili, płytki krwi, nerki i wątroba

✗ Disqualifies

  • Rak piersi w stadium IV (przerzuty odległe)
  • Rak HER-2 dodatni (3+/amplifikowany)
  • Ocena stanu zdrowia wskazująca na znaczną słabość (CARG score ≥4)
  • Chemioterapia w ciągu ostatniego roku przed włączeniem do badania

Simplified criteria — AI translation

Trial details

Minimum age
70 Years
Last updated (source)
August 17, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (7)

Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)

Basking Ridge, United States

Memorial Sloan Kettering at Monmouth (Limited Protocol Activities)

Middletown, United States

Memorial Sloan Kettering at Bergen (Limited Protocol Activities)

Montvale, United States

Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities)

Commack, United States

Memorial Sloan Kettering at Westchester (Limited Protocol Activities)

Harrison, United States

Memorial Sloan-Kettering Cancer Center (All Protocol Activities)

New York, United States

Memorial Sloan Kettering at Nassau (Limited Protocol Activities)

Uniondale, United States

Trial contact

Pamela Drullinsky, MD

Koshy Alexander, MD, MBA

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/18/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.